Establishment of a Quantitative Polymerase Chain Reaction Assay for Monitoring Chimeric Antigen Receptor T Cells in Peripheral Blood

Transplantation Proceedings - Tập 50 - Trang 104-109 - 2018
H. Wang1,2, X. Du1, W.-H. Chen1, J. Lou1, H.-L. Xiao1,2, Y.-M. Pan1, H. Chen1, N. An1, Q.-X. Zhang1
1Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Institute of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
2Guangzhou Medical University, Guangzhou, China

Tài liệu tham khảo

Curran, 2012, Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions, J Gene Med, 14, 405, 10.1002/jgm.2604 Jena, 2010, Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor, Blood, 116, 1035, 10.1182/blood-2010-01-043737 Lipowska-Bhalla, 2012, Targeted immunotherapy of cancer with CAR T cells: achievements and challenges, Cancer Immunol Immunother, 61, 953, 10.1007/s00262-012-1254-0 Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia, N Engl J Med, 368, 1509, 10.1056/NEJMoa1215134 Faitschuk, 2016, Chimeric antigen receptor T cells targeting Fc mu receptor selectively eliminate CLL cells while sparing healthy B cells, Blood, 128, 1711, 10.1182/blood-2016-01-692046 Atanackovic, 2016, Chimeric Antigen Receptor (CAR) therapy for multiple myeloma, Br J Haematol, 172, 685, 10.1111/bjh.13889 Savoldo, 2007, Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease, Blood, 110, 2620, 10.1182/blood-2006-11-059139 Turtle, 2016, Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells, Sci Transl Med, 8, 355ra116, 10.1126/scitranslmed.aaf8621 Torikai, 2012, A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR, Blood, 119, 5697, 10.1182/blood-2012-01-405365 Park, 2016, CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date, Blood, 127, 3312, 10.1182/blood-2016-02-629063 Johnson, 2017, Driving gene-engineered T cell immunotherapy of cancer, Cell Res, 27, 38, 10.1038/cr.2016.154 Maus, 2014, Antibody-modified T cells: CARs take the front seat for hematologic malignancies, Blood, 123, 2625, 10.1182/blood-2013-11-492231 Chen, 2015, CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia, Discov Med, 20, 185 Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia, Sci Transl Med, 3, 95ra73, 10.1126/scitranslmed.3002842 Almasbak, 2016, CAR T cell therapy: A game changer in cancer treatment, J Immunol Res, 2016, 5474602, 10.1155/2016/5474602 Yin, 2010, Detection and quantitation of bluetongue virus serotypes by a TaqMan probe-based real-time RT-PCR and differentiation from epizootic hemorrhagic disease virus, J Virol Methods, 168, 237, 10.1016/j.jviromet.2010.04.018 Cremonesi, 2014, Development of 23 individual TaqMan(R) real-time PCR assays for identifying common foodborne pathogens using a single set of amplification conditions, Food Microbiol, 43, 35, 10.1016/j.fm.2014.04.007 Latif, 2001, Fluorescence polarization in homogeneous nucleic acid analysis II: 5'-nuclease assay, Genome Res, 11, 436, 10.1101/gr.156601 Nagy, 2016, MeltMan: Optimization, Evaluation, and Universal Application of a qPCR System Integrating the TaqMan qPCR and Melting Analysis into a Single Assay, PLoS One, 11, e0151204, 10.1371/journal.pone.0151204 Afonina, 1997, Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder, Nucleic Acids Res, 25, 2657, 10.1093/nar/25.13.2657 Stamova, 2009, Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood, BMC Med Genomics, 2, 49, 10.1186/1755-8794-2-49 Zheng, 2012, Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry, J Transl Med, 10, 29, 10.1186/1479-5876-10-29 De Oliveira, 2013, A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors, J Transl Med, 11, 23, 10.1186/1479-5876-11-23 Emami-Shahri, 2016, Dynamic imaging for CAR-T-cell therapy, Biochem Soc Trans, 44, 386, 10.1042/BST20150257